Nuvation Bio Inc. (NUVB)
NYSE: NUVB · Real-Time Price · USD
7.78
-0.10 (-1.27%)
Dec 2, 2025, 9:54 AM EST - Market open
Nuvation Bio Employees
Nuvation Bio had 220 employees as of December 31, 2024. The number of employees increased by 169 or 331.37% compared to the previous year.
Employees
220
Change (1Y)
169
Growth (1Y)
331.37%
Revenue / Employee
$121,582
Profits / Employee
-$988,545
Market Cap
2.67B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 220 | 169 | 331.37% |
| Dec 31, 2023 | 51 | -2 | -3.77% |
| Dec 31, 2022 | 53 | -11 | -17.19% |
| Dec 31, 2021 | 64 | 28 | 77.78% |
| Dec 31, 2020 | 36 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
NUVB News
- 3 days ago - Nuvation Bio: A Strong Company Now Fairly Priced - Seeking Alpha
- 5 days ago - Nuvation Bio to Participate in Upcoming Investor Conferences - Business Wire
- 10 days ago - Nuvation Bio Inc. (NUVB) Presents at Jefferies London Healthcare Conference 2025 Transcript - Seeking Alpha
- 24 days ago - Nuvation Bio: Ibtrozi's Rollout So Far Confirms Bullish Case - Seeking Alpha
- 4 weeks ago - Nuvation Bio Inc. (NUVB) Q3 2025 Earnings Call Transcript - Seeking Alpha
- 4 weeks ago - Nuvation Bio Reports Third Quarter 2025 Financial Results and Provides Business Update - Business Wire
- 4 weeks ago - Nuvation Bio Chief Scientist Sells 100,000 Shares Under Trading Plan — Here's What to Know About the Stock - The Motley Fool
- 5 weeks ago - Nuvation Bio Enrolls First Patient in Global, Randomized Study of Safusidenib for Maintenance Treatment of High-Grade IDH1-Mutant Glioma - Business Wire